P&G Hygiene & Health Care Q1 Results Live : P&G Hygiene & Health Care declared their Q1 results on 30 October 2024, revealing a mixed performance with revenue declining by 0.28% year-over-year while profit saw a modest increase of 0.57%. In contrast, the company reported significant growth compared to the previous quarter, with revenue surging by 21.83% and profit skyrocketing by 161.41%.
The company’s Selling, General & Administrative (SG&A) expenses rose by 5.71% quarter-over-quarter and increased by 7.49% year-over-year, reflecting higher operational costs amid the challenging market environment.
Despite the dip in revenue, P&G Hygiene & Health Care’s operating income demonstrated remarkable resilience, up by 165.78% sequentially and 3.03% year-over-year, indicating enhanced efficiency and better management of costs.
Earnings per share (EPS) for Q1 stood at ₹65.28, marking a slight increase of 0.57% compared to the same quarter last year. This uptick in EPS may provide some reassurance to investors amidst the revenue decline.
In terms of stock performance, P&G Hygiene & Health Care has faced a -0.33% return over the past week, a 0.48% return over the last six months, and a significant -6.1% year-to-date return, highlighting the volatility in its stock performance this year.
The company’s current market capitalization is ₹52,741.39 crore, with a 52-week high of ₹19,180.35 and a low of ₹15,345.40, showcasing a range of trading activity over the past year.
As of 31 October 2024, among the three analysts covering P&G Hygiene & Health Care, one has assigned a ‘Hold’ rating, another a ‘Buy’ rating, and one a ‘Strong Buy’ rating, reflecting a mix of sentiments among market experts.
The consensus recommendation as of 31 October 2024 suggests a ‘Buy’ rating, indicating optimism regarding the company’s future performance despite recent challenges.
P&G Hygiene & Health Care Financials
| Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 1135.16 | 931.75 | +21.83% | 1138.35 | -0.28% |
| Selling/ General/ Admin Expenses Total | 233.45 | 220.84 | +5.71% | 217.19 | +7.49% |
| Depreciation/ Amortization | 11.7 | 13.4 | -12.69% | 14.3 | -18.18% |
| Total Operating Expense | 856.38 | 826.86 | +3.57% | 867.76 | -1.31% |
| Operating Income | 278.78 | 104.89 | +165.78% | 270.59 | +3.03% |
| Net Income Before Taxes | 285.37 | 112.28 | +154.16% | 284.47 | +0.32% |
| Net Income | 211.9 | 81.06 | +161.41% | 210.69 | +0.57% |
| Diluted Normalized EPS | 65.28 | 27.87 | +134.25% | 64.91 | +0.57% |
